---
title: "A.PLUS GROUP announced its annual performance, reporting a net loss of HKD 1.594 million, turning from profit to loss year-on-year"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/246455254.md"
description: "According to the Zhitong Finance APP, A.PLUS GROUP announced its annual performance for the year ending March 31, 2025, with revenue of HKD 97.845 million, a year-on-year decrease of 21.77%; a net loss of HKD 1.594 million, turning from profit to loss year-on-year; and a loss per share of HKD 0.004"
datetime: "2025-06-27T15:12:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/246455254.md)
  - [en](https://longbridge.com/en/news/246455254.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/246455254.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/246455254.md) | [繁體中文](https://longbridge.com/zh-HK/news/246455254.md)


# A.PLUS GROUP announced its annual performance, reporting a net loss of HKD 1.594 million, turning from profit to loss year-on-year

According to the Zhitong Finance APP, A.PLUS GROUP (01841) announced its annual performance for the year ending March 31, 2025, with revenue of HKD 97.845 million, a year-on-year decrease of 21.77%; a net loss of HKD 1.594 million, turning from profit to loss year-on-year; and a loss per share of HKD 0.004

### Related Stocks

- [A.PLUS GROUP (01841.HK)](https://longbridge.com/en/quote/01841.HK.md)

## Related News & Research

- [Guan Chao's Loss Balloons in 2025](https://longbridge.com/en/news/281314987.md)
- [A Look At Fosun International (SEHK:656) Valuation After Recent Mixed Share Price Performance](https://longbridge.com/en/news/281035263.md)
- [Fosun Pharmaceutical to Set Up Parallel Fund Structure](https://longbridge.com/en/news/281297569.md)
- [Effective measures essential to maintain momentum in export growth](https://longbridge.com/en/news/281300521.md)
- [CSC Financial Sticks to Their Buy Rating for Longfor Group Holdings (LNGPF)](https://longbridge.com/en/news/280898279.md)